Menlo Therapeutics Inc (MNLO) Ownership

Institutions
Mutual Funds

Institutional Ownership

Perceptive Advisors LLC is the biggest individual institutional holder of Menlo Therapeutics Inc (MNLO), owning a total of 22.9 million shares. Combined, the top 20 institutional holders of MNLO own 37.04% of the company with a total of 76.1 million shares.

In the latest ownership report on December 31st 2020, the top 20 institutional holders increased their combined ownership of MNLO by 3.4 million shares. 8 institutions bought 3,516,582 total additional shares and increased their ownership by an average of 10.69%. However 2 institutions sold 124,513 total shares and decreased their ownership by an average of 9.46%.

Overall this is a positive sign as the number of shares owned by the top 20 institutional holders of Menlo Therapeutics increased by a net total of 3,392,069 in the latest quarter.

Institution Ownership Chart

Latest Institutional Ownership Changes

Owner	Percent Owned	Percent Change	Shares Owned	Share Change	Date Reported
Vanguard Group Inc	3.674%	6.647%	7,542,595	470,121	2020-12-31
Franklin Resources Inc	3.291%	0.004%	6,757,053	297	2020-12-31
AXA SA	1.848%	1.693%	3,794,991	63,176	2020-12-31
Geode Capital Management, LLC	1.124%	5.974%	2,307,478	130,070	2020-12-31
Deltec Asset Management LLC	1.021%	0.000%	2,095,400	2,095,400	2020-12-31
Northern Trust Corp	0.752%	-2.015%	1,543,408	-31,733	2020-12-31
JPMorgan Chase & Co	0.288%	42.762%	591,683	177,229	2020-12-31
Bank of New York Mellon Corp	0.268%	28.454%	549,611	121,744	2020-12-31
Tekla Capital Management LLC	0.264%	0.000%	541,584	0	2020-12-31
Renaissance Technologies Corp	0.223%	0.000%	458,545	458,545	2020-12-31
Bank of America Corp	0.222%	-16.900%	456,218	-92,780	2020-12-31

Top Institutions

Owner	Percent Owned	Percent Change	Shares Owned	Share Change	Date Reported
Perceptive Advisors LLC	11.142%	0.000%	22,876,410	0	2020-09-30
BlackRock Inc	4.795%	19.868%	9,845,389	1,631,838	2020-09-30
Vanguard Group Inc	3.674%	6.647%	7,542,595	470,121	2020-12-31
Franklin Resources Inc	3.291%	0.004%	6,757,053	297	2020-12-31
683 Capital Management LLC	2.907%	7.545%	5,968,957	418,749	2020-09-30
Dsc Advisors LP	2.023%	-4.736%	4,152,580	-206,450	2020-09-30
AXA SA	1.848%	1.693%	3,794,991	63,176	2020-12-31
Geode Capital Management, LLC	1.124%	5.974%	2,307,478	130,070	2020-12-31
Deltec Asset Management LLC	1.021%	0.000%	2,095,400	2,095,400	2020-12-31
State Street Corporation	0.937%	31.624%	1,924,068	462,281	2020-09-30
Vivo Capital, LLC	0.887%	0.000%	1,821,912	1,821,912	2020-09-30
Healthcare Value Capital LLC	0.877%	5.882%	1,800,000	100,000	2020-09-30
Northern Trust Corp	0.752%	-2.015%	1,543,408	-31,733	2020-12-31
Nuveen Asset Management, LLC	0.297%	0.000%	609,208	609,208	2020-09-30
JPMorgan Chase & Co	0.288%	42.762%	591,683	177,229	2020-12-31
Bank of New York Mellon Corp	0.268%	28.454%	549,611	121,744	2020-12-31
Tekla Capital Management LLC	0.264%	0.000%	541,584	0	2020-12-31
Renaissance Technologies Corp	0.223%	0.000%	458,545	458,545	2020-12-31
Bank of America Corp	0.222%	-16.900%	456,218	-92,780	2020-12-31
Jacobs Levy Equity Management, Inc.	0.204%	75.726%	417,789	180,039	2020-09-30

Mutual Fund Ownership

Franklin Biotechnology Discovery A is the biggest individual fund holder of Menlo Therapeutics Inc (MNLO), owning a total of 2.9 million shares. Combined, the top 20 mutual fund holders of MNLO own 15.90% of the company with a total of 19.7 million shares.

In the latest ownership report on February 28th 2021, the top 20 fund holders increased their combined ownership of MNLO by 7 thousand shares. 1 funds bought 9,100 total additional shares and increased their ownership by an average of 1.62%. However 1 funds sold 1,794 total shares and decreased their ownership by an average of 0.16%.

Overall this is a positive sign as the number of shares owned by the top 20 mutual funds holding Menlo Therapeutics increased by a net total of 7,306 in the latest report.

Mutual Funds Chart

Latest Mutual Fund Ownership Changes

Owner	Percent Owned	Percent Change	Shares Owned	Share Change	Date Reported
Vanguard Total Stock Mkt Idx Inv	2.221%	-0.157%	1,140,109	-1,794	2021-02-28
Franklin Biotechnology Discv A(acc)USD	1.887%	0.000%	968,539	0	2021-02-28
Vanguard Extended Market Index Investor	1.112%	1.620%	570,968	9,100	2021-02-28

Top Mutual Funds

Owner	Percent Owned	Percent Change	Shares Owned	Share Change	Date Reported
Franklin Biotechnology Discovery A	1.404%	0.000%	2,882,600	0	2021-01-31
MEDICAL BioHealth EUR	1.146%	0.000%	2,351,821	0	2020-12-31
AXA Framlington Health R Inc	1.054%	-15.751%	2,163,639	-404,519	2021-01-31
APO Medical Opportunities R	0.598%	0.000%	1,228,394	0	2020-12-31
Biotech Growth Ord	0.580%	0.000%	1,190,376	0	2020-05-31
Vanguard Total Stock Mkt Idx Inv	2.221%	-0.157%	1,140,109	-1,794	2021-02-28
Fidelity® Small Cap Index	0.505%	0.000%	1,037,431	1,037,431	2020-10-31
AXAWF Fram Longevity Economy A Cap USD	0.482%	-19.294%	990,124	-236,709	2021-01-31
Franklin Biotechnology Discv A(acc)USD	1.887%	0.000%	968,539	0	2021-02-28
iShares Russell 2000 ETF	1.697%	-0.113%	871,252	-987	2021-02-26
Fidelity® Extended Market Index	0.361%	0.000%	740,736	0	2021-01-31
Vifag 2002 SICAV	0.315%	0.000%	647,648	647,648	2020-09-30
Vanguard Extended Market Index Investor	1.112%	1.620%	570,968	9,100	2021-02-28
NT R2000 Index Fund - NL	0.258%	2.366%	530,418	12,258	2020-12-31
NT R2000 Value Index Fund - NL	0.242%	-4.764%	496,124	-24,820	2020-12-31
iShares Nasdaq Biotechnology ETF	0.811%	0.439%	416,092	1,818	2021-02-26
Tekla Healthcare Investors	0.185%	0.000%	379,103	0	2020-09-30
RIM Global Bioscience EUR	0.182%	0.000%	374,138	0	2020-12-31
BlackRock Extended Equity Market K	0.178%	-7.747%	365,034	-30,653	2020-12-31
iShares Russell 2000 Value ETF	0.680%	0.731%	349,164	2,534	2021-02-26